vs

Side-by-side financial comparison of Gitlab Inc. (GTLB) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Gitlab Inc. is the larger business by last-quarter revenue ($244.4M vs $142.0M, roughly 1.7× Oncology Institute, Inc.). Gitlab Inc. runs the higher net margin — -3.4% vs -5.3%, a 1.9% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 24.6%). Gitlab Inc. produced more free cash flow last quarter ($28.4M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 22.1%).

GitLab Inc. is an American company that operates and develops GitLab, an open-core DevOps software package that can develop, secure, and operate software. GitLab includes a distributed version control system based on Git, including features such as access control, bug tracking, software feature requests, task management, and wikis for every project, as well as snippets.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

GTLB vs TOI — Head-to-Head

Bigger by revenue
GTLB
GTLB
1.7× larger
GTLB
$244.4M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+16.9% gap
TOI
41.6%
24.6%
GTLB
Higher net margin
GTLB
GTLB
1.9% more per $
GTLB
-3.4%
-5.3%
TOI
More free cash flow
GTLB
GTLB
$26.2M more FCF
GTLB
$28.4M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
22.1%
GTLB

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
GTLB
GTLB
TOI
TOI
Revenue
$244.4M
$142.0M
Net Profit
$-8.3M
$-7.5M
Gross Margin
86.8%
Operating Margin
-5.1%
-4.9%
Net Margin
-3.4%
-5.3%
Revenue YoY
24.6%
41.6%
Net Profit YoY
-128.0%
43.0%
EPS (diluted)
$-0.05
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GTLB
GTLB
TOI
TOI
Q4 25
$244.4M
$142.0M
Q3 25
$236.0M
$136.6M
Q2 25
$214.5M
$119.8M
Q1 25
$211.4M
$104.4M
Q4 24
$196.0M
$100.3M
Q3 24
$182.6M
$99.9M
Q2 24
$169.2M
$98.6M
Q1 24
$163.8M
$94.7M
Net Profit
GTLB
GTLB
TOI
TOI
Q4 25
$-8.3M
$-7.5M
Q3 25
$-9.2M
$-16.5M
Q2 25
$-35.9M
$-17.0M
Q1 25
$5.8M
$-19.6M
Q4 24
$29.6M
$-13.2M
Q3 24
$12.9M
$-16.1M
Q2 24
$-54.6M
$-15.5M
Q1 24
$-36.5M
$-19.9M
Gross Margin
GTLB
GTLB
TOI
TOI
Q4 25
86.8%
Q3 25
87.9%
Q2 25
88.3%
Q1 25
89.2%
Q4 24
88.7%
Q3 24
88.3%
Q2 24
88.9%
Q1 24
90.2%
Operating Margin
GTLB
GTLB
TOI
TOI
Q4 25
-5.1%
-4.9%
Q3 25
-7.8%
-5.9%
Q2 25
-16.1%
-9.4%
Q1 25
-9.1%
-9.5%
Q4 24
-14.7%
-11.9%
Q3 24
-22.5%
-13.9%
Q2 24
-31.7%
-16.6%
Q1 24
-21.3%
-19.0%
Net Margin
GTLB
GTLB
TOI
TOI
Q4 25
-3.4%
-5.3%
Q3 25
-3.9%
-12.1%
Q2 25
-16.7%
-14.2%
Q1 25
2.7%
-18.8%
Q4 24
15.1%
-13.1%
Q3 24
7.1%
-16.1%
Q2 24
-32.3%
-15.7%
Q1 24
-22.3%
-21.0%
EPS (diluted)
GTLB
GTLB
TOI
TOI
Q4 25
$-0.05
$-0.04
Q3 25
$-0.06
$-0.14
Q2 25
$-0.22
$-0.15
Q1 25
$0.05
$-0.21
Q4 24
$0.18
$-0.14
Q3 24
$0.08
$-0.18
Q2 24
$-0.35
$-0.17
Q1 24
$-0.23
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GTLB
GTLB
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$224.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$922.7M
$-15.7M
Total Assets
$1.6B
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GTLB
GTLB
TOI
TOI
Q4 25
$224.2M
Q3 25
$261.4M
Q2 25
$255.7M
Q1 25
$227.6M
Q4 24
$176.6M
Q3 24
$438.6M
Q2 24
$420.3M
$9.9M
Q1 24
$288.0M
$29.8M
Stockholders' Equity
GTLB
GTLB
TOI
TOI
Q4 25
$922.7M
$-15.7M
Q3 25
$866.6M
$-12.3M
Q2 25
$808.3M
$-9.0M
Q1 25
$775.9M
$5.1M
Q4 24
$724.7M
$3.6M
Q3 24
$642.8M
$15.5M
Q2 24
$567.8M
$29.2M
Q1 24
$571.2M
$41.3M
Total Assets
GTLB
GTLB
TOI
TOI
Q4 25
$1.6B
$164.7M
Q3 25
$1.5B
$163.6M
Q2 25
$1.4B
$159.8M
Q1 25
$1.4B
$164.0M
Q4 24
$1.3B
$172.7M
Q3 24
$1.4B
$179.2M
Q2 24
$1.3B
$179.6M
Q1 24
$1.3B
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GTLB
GTLB
TOI
TOI
Operating Cash FlowLast quarter
$31.4M
$3.2M
Free Cash FlowOCF − Capex
$28.4M
$2.2M
FCF MarginFCF / Revenue
11.6%
1.5%
Capex IntensityCapex / Revenue
1.2%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$242.3M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GTLB
GTLB
TOI
TOI
Q4 25
$31.4M
$3.2M
Q3 25
$49.4M
$-12.6M
Q2 25
$106.3M
$-10.2M
Q1 25
$63.2M
$-5.0M
Q4 24
$-177.0M
$4.2M
Q3 24
$11.7M
$819.0K
Q2 24
$38.1M
$-15.7M
Q1 24
$24.9M
$-15.9M
Free Cash Flow
GTLB
GTLB
TOI
TOI
Q4 25
$28.4M
$2.2M
Q3 25
$46.5M
$-13.2M
Q2 25
$105.4M
$-11.4M
Q1 25
$62.1M
$-5.3M
Q4 24
$-178.1M
$2.4M
Q3 24
$10.8M
$417.0K
Q2 24
$37.4M
$-17.5M
Q1 24
$24.5M
$-16.5M
FCF Margin
GTLB
GTLB
TOI
TOI
Q4 25
11.6%
1.5%
Q3 25
19.7%
-9.7%
Q2 25
49.1%
-9.5%
Q1 25
29.4%
-5.1%
Q4 24
-90.8%
2.4%
Q3 24
5.9%
0.4%
Q2 24
22.1%
-17.7%
Q1 24
15.0%
-17.4%
Capex Intensity
GTLB
GTLB
TOI
TOI
Q4 25
1.2%
0.7%
Q3 25
1.2%
0.4%
Q2 25
0.4%
1.0%
Q1 25
0.5%
0.3%
Q4 24
0.5%
1.8%
Q3 24
0.5%
0.4%
Q2 24
0.4%
1.9%
Q1 24
0.2%
0.6%
Cash Conversion
GTLB
GTLB
TOI
TOI
Q4 25
Q3 25
Q2 25
Q1 25
10.89×
Q4 24
-5.99×
Q3 24
0.90×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GTLB
GTLB

Subscription And Circulation$146.4M60%
Subscription Software As A Service$76.9M31%
License$15.5M6%
Professional Services And Other$5.6M2%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons